Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Kazia Therapeutics Limited
13G/A
Amendment 1
KZIA · 48669G303
|
4.6% |
8/14/2026
Event 6/30/2026
|
|||
| Lynwood Capital Management Inc. | 4.6% | ||||
| Ben Shapiro | 4.6% | ||||
| Lynwood Opportunities Master Fund | 4.6% | ||||
|
Rein Therapeutics, Inc.
13G/A
Amendment 1
RNTX · 00887A204
|
5.0% |
8/14/2026
Event 6/30/2026
|
|||
| Lynwood Capital Management Inc. | 5.0% | ||||
| Ben Shapiro | 5.0% | ||||
| Lynwood Opportunities Master Fund | 5.0% | ||||
|
Rein Therapeutics, Inc.
13G
RNTX · 00887A204
|
6.1% |
5/8/2026
Event 5/4/2026
|
|||
| Lynwood Capital Management Inc. | 6.1% | ||||
| Benjamin Shapiro | 6.1% | ||||
| Lynwood Opportunities Master Fund | 6.1% | ||||
|
Kazia Therapeutics Limited
13G
KZIA · 48669G303
|
5.4% |
1/23/2026
Event 1/15/2026
|
|||
| Lynwood Capital Management Inc. | 5.4% | ||||
| Ben Shapiro | 5.4% | ||||
| Lynwood Opportunities Master Fund | 5.4% | ||||